Stephen L Sabba
CIK 1442372 · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.25M
Companies
3
Total Filings
44
Lifetime Open-Market Net
-$6.14M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-13 | LGND | Sell (S) | −622 | -$112.4K | EDGAR |
| 2017-12-21 | LGND | Sell (S) | −925 | -$127.0K | EDGAR |
| 2017-05-30 | LGND | Grant (A) | +666 | $0 | EDGAR |
| 2016-12-27 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-21 | QLTI | Grant (A) | — | $0 | EDGAR |
| 2016-05-25 | LGND | Grant (A) | +622 | $0 | EDGAR |
| 2015-07-01 | QLTI | Exer (M) | +25,000 | $87.1K | EDGAR |
| 2015-06-09 | QLTI | Exer (M) | +10,000 | $0 | EDGAR |
| 2015-04-28 | LGND | Grant (A) | +925 | $0 | EDGAR |
| 2014-12-19 | QLTI | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.